Suppr超能文献

严重急性呼吸综合征冠状病毒2:关于其起源及脂肪来源间充质干细胞作为新型潜在免疫调节武器的“未经审查”的真相

SARS-CoV-2: the "Uncensored" Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon.

作者信息

Gentile Pietro

机构信息

1Department of Surgical Science, Plastic and Reconstructive Surgery, "Tor Vergata" University, Rome, 00133, Italy.

2Founder and Scientific Director of Academy of International Regenerative Medicine & Surgery Societies (AIRMESS), 1201 Geneva, Switzerland.

出版信息

Aging Dis. 2021 Apr 1;12(2):330-344. doi: 10.14336/AD.2021.0121. eCollection 2021 Apr.

Abstract

In this second return of the pandemic, January 2021, it appears to be clear that a Nano-sized organism, the SARS-CoV-2, has rendered the human race helpless, made the global health status decline, and drowned the world economy. However, it does not appear clear the real origin of the SARS-CoV-2 and the aim of this work is to report and discuss, maybe for the first time since the pandemic began, the scientific data published in this specific field, analyzing the potentially available weapons against the SARS-CoV-2. About this last point, a ray of hope comes from the potential of Mesenchymal Stem Cells (MSCs) that has already been established in Coronavirus Disease 2019 (COVID-19), and in particular from the Adipose-Derived Mesenchymal Stem Cells (AD-MSCs). However, cell-based therapy has its own limits, especially represented by the know-how in this field and by the rules of applications. It was suggested a biological therapy using AD-MSCs as a weapon against COVID-19, as they can be a game-changer owing to their immuno-modulatory nature, which combats the cytokine storm characterizing this disease, and their practical efficiency, which will realistically aid large access to therapy worldwide.

摘要

在2021年1月疫情的这第二轮反扑中,似乎很明显,一种纳米级别的生物体——严重急性呼吸综合征冠状病毒2(SARS-CoV-2),已使人类束手无策,导致全球健康状况下降,并拖累了世界经济。然而,SARS-CoV-2的真正起源似乎并不明确,而这项工作的目的是报告并讨论,也许是自疫情开始以来首次,该特定领域已发表的科学数据,分析针对SARS-CoV-2的潜在可用武器。关于最后这一点,一线希望来自间充质干细胞(MSCs)的潜力,这种潜力在2019冠状病毒病(COVID-19)中已经得到证实,尤其是来自脂肪来源的间充质干细胞(AD-MSCs)。然而,基于细胞的疗法有其自身的局限性,特别是体现在该领域的专业技术和应用规则方面。有人提出使用AD-MSCs作为对抗COVID-19的武器进行生物治疗,因为它们具有免疫调节特性,能够对抗该疾病特有的细胞因子风暴,且其实用效率能切实帮助在全球范围内实现大规模治疗,可能会带来改变局面的效果。

相似文献

3
Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
Curr Stem Cell Res Ther. 2024;19(5):644-652. doi: 10.2174/1574888X18666230417085117.
6
Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
Stem Cell Res Ther. 2021 Mar 1;12(1):155. doi: 10.1186/s13287-021-02216-w.
7
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.
Stem Cells Transl Med. 2021 Apr;10(4):636-642. doi: 10.1002/sctm.20-0385. Epub 2021 Jan 26.
8
Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease.
Aging Dis. 2020 May 9;11(3):465-469. doi: 10.14336/AD.2020.0422. eCollection 2020 May.
9
Mesenchymal stem cells and their derived exosomes to combat Covid-19.
Rev Med Virol. 2022 Mar;32(2):e2281. doi: 10.1002/rmv.2281. Epub 2021 Aug 7.
10
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19.
Regen Eng Transl Med. 2022;8(1):43-54. doi: 10.1007/s40883-021-00202-5. Epub 2021 Mar 10.

引用本文的文献

1
Proteins from Stressed Mesenchymal Stem Cells Can Repair Hair Follicles and Promote Hair Regeneration.
ACS Pharmacol Transl Sci. 2025 May 24;8(6):1768-1777. doi: 10.1021/acsptsci.5c00184. eCollection 2025 Jun 13.
2
The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy.
Stem Cell Res Ther. 2023 Dec 20;14(1):381. doi: 10.1186/s13287-023-03587-y.
5
An Update on Adipose-Derived Stem Cells for Regenerative Medicine: Where Challenge Meets Opportunity.
Adv Sci (Weinh). 2023 Jul;10(20):e2207334. doi: 10.1002/advs.202207334. Epub 2023 May 10.
6
Methods and Limitations of Augmenting Mesenchymal Stem Cells for Therapeutic Applications.
Adv Wound Care (New Rochelle). 2023 Aug;12(8):467-481. doi: 10.1089/wound.2022.0107. Epub 2022 Dec 8.
9
Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis.
EClinicalMedicine. 2022 Jul 9;51:101545. doi: 10.1016/j.eclinm.2022.101545. eCollection 2022 Sep.

本文引用的文献

1
SARS-CoV-2 spillover events.
Science. 2021 Jan 8;371(6525):120-122. doi: 10.1126/science.abf6097.
3
Exosome therapeutics for lung regenerative medicine.
J Extracell Vesicles. 2020 Jun 29;9(1):1785161. doi: 10.1080/20013078.2020.1785161.
4
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
Stem Cell Res Ther. 2020 Aug 14;11(1):356. doi: 10.1186/s13287-020-01866-6.
6
Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease.
Aging Dis. 2020 May 9;11(3):465-469. doi: 10.14336/AD.2020.0422. eCollection 2020 May.
7
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
Stem Cells Dev. 2020 Jun 15;29(12):747-754. doi: 10.1089/scd.2020.0080. Epub 2020 May 12.
8
Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia.
Expert Opin Biol Ther. 2020 Jul;20(7):711-716. doi: 10.1080/14712598.2020.1761322. Epub 2020 Apr 29.
9
Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality.
Sci Adv. 2020 Apr 8;6(15):eaaz6980. doi: 10.1126/sciadv.aaz6980. eCollection 2020 Apr.
10
Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia.
Aging Dis. 2020 Mar 9;11(2):462-464. doi: 10.14336/AD.2020.0301. eCollection 2020 Apr.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验